PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ZTS vs. CAH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ZTS and CAH is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

ZTS vs. CAH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zoetis Inc. (ZTS) and Cardinal Health, Inc. (CAH). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%AugustSeptemberOctoberNovemberDecember2025
-6.39%
34.57%
ZTS
CAH

Key characteristics

Sharpe Ratio

ZTS:

-0.46

CAH:

1.03

Sortino Ratio

ZTS:

-0.49

CAH:

1.52

Omega Ratio

ZTS:

0.94

CAH:

1.20

Calmar Ratio

ZTS:

-0.29

CAH:

1.23

Martin Ratio

ZTS:

-0.94

CAH:

2.65

Ulcer Index

ZTS:

12.08%

CAH:

8.45%

Daily Std Dev

ZTS:

25.05%

CAH:

21.70%

Max Drawdown

ZTS:

-46.52%

CAH:

-61.58%

Current Drawdown

ZTS:

-30.38%

CAH:

0.00%

Fundamentals

Market Cap

ZTS:

$75.58B

CAH:

$30.94B

EPS

ZTS:

$5.33

CAH:

$5.20

PE Ratio

ZTS:

31.43

CAH:

24.58

PEG Ratio

ZTS:

2.58

CAH:

1.04

Total Revenue (TTM)

ZTS:

$6.94B

CAH:

$167.06B

Gross Profit (TTM)

ZTS:

$4.86B

CAH:

$5.59B

EBITDA (TTM)

ZTS:

$3.02B

CAH:

$1.90B

Returns By Period

In the year-to-date period, ZTS achieves a 2.82% return, which is significantly lower than CAH's 8.55% return. Over the past 10 years, ZTS has outperformed CAH with an annualized return of 15.13%, while CAH has yielded a comparatively lower 7.44% annualized return.


ZTS

YTD

2.82%

1M

1.63%

6M

-6.38%

1Y

-11.71%

5Y*

4.67%

10Y*

15.13%

CAH

YTD

8.55%

1M

8.54%

6M

34.57%

1Y

23.62%

5Y*

22.06%

10Y*

7.44%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ZTS vs. CAH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZTS
The Risk-Adjusted Performance Rank of ZTS is 2323
Overall Rank
The Sharpe Ratio Rank of ZTS is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of ZTS is 1919
Sortino Ratio Rank
The Omega Ratio Rank of ZTS is 2020
Omega Ratio Rank
The Calmar Ratio Rank of ZTS is 2828
Calmar Ratio Rank
The Martin Ratio Rank of ZTS is 2323
Martin Ratio Rank

CAH
The Risk-Adjusted Performance Rank of CAH is 7575
Overall Rank
The Sharpe Ratio Rank of CAH is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of CAH is 7272
Sortino Ratio Rank
The Omega Ratio Rank of CAH is 7070
Omega Ratio Rank
The Calmar Ratio Rank of CAH is 8282
Calmar Ratio Rank
The Martin Ratio Rank of CAH is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ZTS vs. CAH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Zoetis Inc. (ZTS) and Cardinal Health, Inc. (CAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ZTS, currently valued at -0.46, compared to the broader market-2.000.002.004.00-0.461.03
The chart of Sortino ratio for ZTS, currently valued at -0.49, compared to the broader market-4.00-2.000.002.004.006.00-0.491.52
The chart of Omega ratio for ZTS, currently valued at 0.94, compared to the broader market0.501.001.502.000.941.20
The chart of Calmar ratio for ZTS, currently valued at -0.29, compared to the broader market0.002.004.006.00-0.291.23
The chart of Martin ratio for ZTS, currently valued at -0.94, compared to the broader market0.0010.0020.0030.00-0.942.65
ZTS
CAH

The current ZTS Sharpe Ratio is -0.46, which is lower than the CAH Sharpe Ratio of 1.03. The chart below compares the historical Sharpe Ratios of ZTS and CAH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
-0.46
1.03
ZTS
CAH

Dividends

ZTS vs. CAH - Dividend Comparison

ZTS's dividend yield for the trailing twelve months is around 0.77%, less than CAH's 1.58% yield.


TTM20242023202220212020201920182017201620152014
ZTS
Zoetis Inc.
0.77%1.06%0.76%0.89%0.41%0.48%0.50%0.59%0.58%0.71%0.69%0.67%
CAH
Cardinal Health, Inc.
1.58%1.28%1.98%2.57%3.80%3.62%3.79%4.24%2.99%2.41%1.68%1.65%

Drawdowns

ZTS vs. CAH - Drawdown Comparison

The maximum ZTS drawdown since its inception was -46.52%, smaller than the maximum CAH drawdown of -61.58%. Use the drawdown chart below to compare losses from any high point for ZTS and CAH. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-30.38%
0
ZTS
CAH

Volatility

ZTS vs. CAH - Volatility Comparison

Zoetis Inc. (ZTS) has a higher volatility of 5.99% compared to Cardinal Health, Inc. (CAH) at 4.09%. This indicates that ZTS's price experiences larger fluctuations and is considered to be riskier than CAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%AugustSeptemberOctoberNovemberDecember2025
5.99%
4.09%
ZTS
CAH

Financials

ZTS vs. CAH - Financials Comparison

This section allows you to compare key financial metrics between Zoetis Inc. and Cardinal Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab